Stocks · Health care · Pharmaceutical Preparations

Protagonist Therapeutics, Inc

PTGX Clue Score48
United States Fiscal year ends December CIK 0001377121 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
William D. Waddill
22 Sep 2025
Director
Sold on a plan
4,000
$64.25
$257.00K
William D. Waddill
27 Aug 2025
Director
Sold on a plan
4,000
$59.25
$237.00K
William D. Waddill
17 Mar 2025
Director
Sold on a plan
4,000
$54.25
$217.00K
Dinesh V Ph D Patel
7 Jun 2024
President and CEO
Sold on a plan
35,000
$35.19
$1.23M
Dinesh V Ph D Patel
1 Apr 2024
President and CEO
Sold on a plan
25,000
$28.31
$707.75K
Dinesh V Ph D Patel
1 Mar 2024
President and CEO
Sold on a plan
30,000
$31.62
$948.60K
Dinesh V Ph D Patel
13 Dec 2023
President and CEO
Sold on a plan
75,000
$20.08
$1.51M

What was left out

Form 4 filings counted 247
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 7
Sales on a Rule 10b5-1 plan 7
Sales straight out of an exercise 70
Sales at will 49
Transactions with no price 0
Shares from compensation/vesting 2,924,555
Sales filed before the plan box existed 25
History held since 16 Aug 2016